Fetal malformation risk not increased after exposure to lamotrigine
A new analysis of registry data from European countries does not support a risk of orofacial cleft and clubfoot with exposure to lamotrigine monotherapy, in contrast to signals from previous studies of the antiepileptic drug.
See this content immediately after install